About 130,000 results
https://www.nasdaq.com/symbol/cytkStock quote for Cytokinetics, Incorporated Common Stock Common Stock (CYTK)
with real-time last sale and extended hours stock prices, company news, charts,
and research at Nasdaq.
https://www.nasdaq.com/symbol/cytk/stock-reportAnalyze Cytokinetics, Incorporated (CYTK) Company Stock Report - Get free
stock reports for Cytokinetics, Incorporated and all the companies you research at
... Pre-Market Most Active for Nov 21, 2017 : QD, XNET, URBN, SIG, CYTK, LOW, TVIX, AKS, DLTR, BABA, MT, MU.
... Is the Options Market Predicting a Spike in Cytokinetics (CYTK) Stock?
https://finance.yahoo.com/quote/CYTK/What You Must Know About Cytokinetics Incorporated's (NASDAQ:CYTK) Major
Investors. Today, I will be analyzing Cytokinetics Incorporated's (NASDAQ:CYTK)
recent ownership structure, an important but not-so-popular subject among
individual investors. When it comes to ownership structure of a company, the ...
https://stocktwits.com/symbol/CYTKHouse Rules · Best Practices · Developers · Careers · Terms · Privacy ·
Disclaimer · itunes play. Connect with us: Advertise with us. ©2018 StockTwits,
Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price.
Cytokinetics Inc. CYTK8.35. 0.15 (1.77%). NASDAQUPDATED Mar 22, 2018 8:39
https://www.thestreet.com/quote/CYTK.htmlView detailed financial information, real-time news, videos, quotes and analysis
on Cytokinetics Inc. (NASDAQ:CYTK). Explore commentary on Cytokinetics Inc.
and hear what the experts at TheStreet are saying about CYTK.
https://www.marketwatch.com/investing/stock/cytkCytokinetics Inc. stock price, stock quotes and financial overviews from
https://simplywall.st/.../nasdaq-cytk/.../can-cytokinetics-incorporated- nasdaqcytk-improve-your-portfolio-returns/Feb 16, 2018 ... For Cytokinetics Incorporated's (NASDAQ:CYTK) shareholders, and also
potential investors in the stock, understanding how the stock's risk and return
characteristics can impact your portfolio is important.
https://www.benzinga.com/.../b-cytokinetics-b-s-earnings-outlookFeb 15, 2018 ... Cytokinetics (NASDAQ: CYTK) announces its next round of earnings Thursday.
Here is Benzinga's everything-that-matters guide for today's Q4 earnings ...
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
CEO: Robert I. Blum
Chairperson: L. Patrick Gage
Headquarters: South San Francisco, CA
Chief medical officer: Andrew A. Wolff (Facc)
CFO: Ching W. Jaw